Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Boterberg

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II studyAnne Demols, Marc Peeters, Marc Polus, et al.
Journal of the National Cancer Institute|March 2, 1999
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancerM E Bracke, H T Depypere, T Boterberg, et al.
ESMO Open|April 10, 2026
Patterns and quality of therapeutic care for glioma: a population-based study in Belgium between 2016 and 2019D Vanhauwaert, K Vanschoenbeek, G Silvermit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2009
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II studyS Laurent, E Monsaert, T Boterberg, et al.
Journal of Neuro-Oncology|November 9, 2019
Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort studyH Pinson, G Hallaert, J Van der Meulen, et al.
European Journal of Cancer Care|January 29, 2014
Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of lifeL Pottel, M Lycke, T Boterberg, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2020
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experienceP Berlanga, C Pasqualini, U Pötschger, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II studyAnne Demols, Marc Peeters, Marc Polus, et al.
Journal of the National Cancer Institute|March 2, 1999
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancerM E Bracke, H T Depypere, T Boterberg, et al.
ESMO Open|April 10, 2026
Patterns and quality of therapeutic care for glioma: a population-based study in Belgium between 2016 and 2019D Vanhauwaert, K Vanschoenbeek, G Silvermit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2009
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II studyS Laurent, E Monsaert, T Boterberg, et al.
Journal of Neuro-Oncology|November 9, 2019
Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort studyH Pinson, G Hallaert, J Van der Meulen, et al.
European Journal of Cancer Care|January 29, 2014
Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of lifeL Pottel, M Lycke, T Boterberg, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2020
Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experienceP Berlanga, C Pasqualini, U Pötschger, et al.
Pageof 3